The American Roentgen Ray Society – Page 2

PCa Upgrade and Downgrade Rates for PI-RADS v2.0 Versus v2.1

October 16, 2024

Unavailable

PET/CT for Peritoneal Metastases

October 16, 2024

Unavailable

FDG PET/CT and Lymphoma Treated With CAR T-Cell Therapy

October 16, 2024

Unavailable

AKI Risk After IV Iodinated Contrast Media Exposure

October 16, 2024

Unavailable

Unilateral Axillary Lymphadenopathy on Breast MRI

July 30, 2024

Unavailable

Selective Surgical Excision of Benign Papillomas Diagnosed at CNB

July 30, 2024

Unavailable

Small-Bowel Neuroendocrine Neoplasms

July 30, 2024

Unavailable

Architectural Distortion on Tomosynthesis

July 29, 2024

Unavailable

Breast Cancer Staging

July 29, 2024

Unavailable

UIP and Percutaneous Transthoracic Needle Lung Biopsy

March 25, 2024

Unavailable

Locoregional Therapies for Primary and Metastatic Breast Cancer

March 25, 2024

Unavailable

Imaging Tests in Patients Presenting to ED With Dizziness

March 25, 2024

Unavailable

CEM After Breast Cancer Cryoblation

March 25, 2024

Unavailable

Size Threshold for MRI-Detected Retropharyngeal Lymph Nodes

February 12, 2024

Unavailable

Imaging Alcohol-Associated Liver Disease

February 12, 2024

Unavailable

Scintigraphy for Cardiac Amyloidosis Diagnosis

February 12, 2024

Unavailable

DWI for Breast Cancer Diagnosis and Treatment Monitoring

February 12, 2024

Unavailable

Adrenal Mass Biopsy

February 12, 2024

Unavailable

Synoptic Reporting for Pretreatment CT of Ovarian Cancer

December 13, 2023

Unavailable

MRI-Based Staging for Predicting BCR of PCa After RP

December 4, 2023

Unavailable

Retained BSMs After Breast Lesion Resection

November 13, 2023

Unavailable

PRECISE Recommendations for Prostate MRI

November 13, 2023

Unavailable

Diagnosis and Management of Pelvic Venous Disorders

November 13, 2023

Unavailable

Assessing Response to Therapy in Molecular Imaging:

October 11, 2023

Unavailable

For more than 30 years, MECOP has been an ACCME-accredited provider of continuing medical education for physicians.

PCa Upgrade and Downgrade Rates for PI-RADS v2.0 Versus v2.1

PET/CT for Peritoneal Metastases

FDG PET/CT and Lymphoma Treated With CAR T-Cell Therapy

AKI Risk After IV Iodinated Contrast Media Exposure

Unilateral Axillary Lymphadenopathy on Breast MRI

Selective Surgical Excision of Benign Papillomas Diagnosed at CNB

Small-Bowel Neuroendocrine Neoplasms

Architectural Distortion on Tomosynthesis

Breast Cancer Staging

UIP and Percutaneous Transthoracic Needle Lung Biopsy

Locoregional Therapies for Primary and Metastatic Breast Cancer

Imaging Tests in Patients Presenting to ED With Dizziness

CEM After Breast Cancer Cryoblation

Size Threshold for MRI-Detected Retropharyngeal Lymph Nodes

Imaging Alcohol-Associated Liver Disease

Scintigraphy for Cardiac Amyloidosis Diagnosis

DWI for Breast Cancer Diagnosis and Treatment Monitoring

Adrenal Mass Biopsy

Synoptic Reporting for Pretreatment CT of Ovarian Cancer

MRI-Based Staging for Predicting BCR of PCa After RP

Retained BSMs After Breast Lesion Resection

PRECISE Recommendations for Prostate MRI

Diagnosis and Management of Pelvic Venous Disorders

Assessing Response to Therapy in Molecular Imaging:

Upcoming Events

Quick Links

Contact Us